ICICI BANK LTD (IBN)
NYSEFinancialsBanks - RegionalSnapshot 2026-11-04
$31.26+3.75%
Close 2026-11-04 · 1-day change
NYSEFinancialsBanks - RegionalSnapshot 2026-11-04
Research Workspace
Put IBN beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Regional Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — earnings per share growth: Comparison needs review.
View ThesisModerate volatility — typically moves about 1% a day.
View RiskIBN's loan book expansion has to keep compounding to justify the price. Net profit surged 22% in the latest quarter. The sector backdrop is currently supportive for the bank. No valuation bridge data is present on the desk. The thesis comparison is not yet verified. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-04. IBN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering IBN (as of Nov 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare IBN with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| IBN Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Regional Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put IBN next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
FCNR(B) funding costs pressure Q2 margins, though an expected recovery limits the headwind.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Reported earnings beat and target increases support the outlook, though remain broker interpretations.
Earnings miss is a meaningful performance setback, though revenue in line limits the negative signal.
20% profit growth is meaningful, though slightly softer core profitability tempers the positive signal.
Strong profit growth and loan expansion are meaningful operating positives, though one quarter is not thesis-defining.
Strong profit growth is meaningful, though lower NIM partly offsets the earnings advance.
Reported 23% profit growth is a meaningful earnings positive, tempered by margin pressure.
Expected FCNR-B funding costs point to further margin compression, a meaningful near-term earnings headwind.
